Dyadic International (DYAI) Interest Coverage Ratio (2018 - 2026)
Dyadic International (DYAI) posted Interest Coverage Ratio of 18.69 for Q1 2026, down 116.23% sequentially from 115.19 in Q4 2025, and little changed YoY from 18.7 in Q1 2025.
Dyadic International (DYAI) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
Dyadic International has reported Interest Coverage Ratio for 9 years, with the latest figure at 18.69 in Q1 2026.
- Quarterly Interest Coverage Ratio changed 0.03% year-over-year to 18.69 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.5 (down 25.03% YoY) and the FY2025 annual result came in at 0.38, down 13.11% from the prior year.
- Interest Coverage Ratio eased to 18.69 in Q1 2026 per DYAI's latest filing, from 115.19 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 115.19 in Q4 2025 and troughed at 172.27 in Q4 2022.
- A 5-year average of 28.34 and a median of 9.07 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 34280.76% in 2022, then soared 1267.98% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 172.27 in 2022, then surged by 98.15% to 3.19 in 2023, then tumbled by 209.16% to 9.86 in 2024, then jumped by 1267.98% to 115.19 in 2025, then plunged by 116.23% to 18.69 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 18.69, 115.19, and 22.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Dyadic International | 20.18 Mn | 20.18 Mn | - | -29.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.69 |
| Dec 31, 2025 | 115.19 |
| Sep 30, 2025 | -22.41 |
| Jun 30, 2025 | -8.27 |
| Mar 31, 2025 | -18.68 |
| Dec 31, 2024 | -9.86 |
| Sep 30, 2024 | -1.76 |
| Jun 30, 2024 | -154.68 |
| Mar 31, 2024 | -98.23 |
| Mar 31, 2023 | -3.19 |
| Dec 31, 2022 | -172.27 |
| Sep 30, 2022 | -2.42 |
| Jun 30, 2022 | -0.81 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -0.50 |
| Sep 30, 2021 | -0.27 |
| Jun 30, 2021 | -0.65 |
| Mar 31, 2021 | -233.69 |
| Dec 31, 2020 | -0.17 |
| Sep 30, 2020 | -0.11 |